About
Born from one person’s passion to help global audiences make sense of China’s fast-evolving market access landscape for innovative medicines, NRDL+ has grown from a newsletter into a real-time health policy intelligence platform through Access360. We surface what matters—translating complex policy shifts into actionable insights with tangible commercial impact for life sciences leaders.
To fully unlock China’s market potential, global and local teams need a holistic understanding of its multi-layered access environment. That’s where our Speaker Program and Masterclass come in. Each combines a strategic primer with critical policy trends—helping teams connect the dots and make better, faster, and more informed decisions.
NRDL+ Executive Debrief is powered by bizi LLC, a New Jersey-based consultancy with over a decade of experience guiding life sciences leaders through pricing, reimbursement, and market access challenges across global and local markets.
People
Kelly Ke
Founder, bizi LLC | Author, NRDL+ Executive Debrief
Kelly spent ten years as an award-winning senior advisor in Deloitte US’s Life Sciences practice before founding bizi LLC, a firm that has guided life sciences companies through pricing, reimbursement, and access challenges across global and local markets for more than a decade.
Operating at the intersection of health policy, commercial strategy, and execution, Kelly helps global leaders translate China’s evolving policy landscape into market-informed decisions. She is the author of the NRDL+ Executive Debrief, a widely followed newsletter on China market access, read by executives from over two-thirds of the world’s top 30 pharmaceutical companies—as well as leading biotechs, insurers, hospital groups, and academic institutions such as Harvard, USC, UCLA, and Northwestern Kellogg.
She is supported by a curated network of top China experts, enabling NRDL+ to deliver balanced perspectives and real-world insight into policy design and implementation.
Originally from Beijing, Kelly holds master’s degrees from the University of Southern California and the University of Utah, along with a postgraduate certificate in International Health Technology Assessment (HTA) and Reimbursement from the University of Sheffield.